昊海生科
(688366)
| 流通市值：98.48亿 | | | 总市值：118.35亿 |
| 流通股本：1.94亿 | | | 总股本：2.33亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 618,542,128.87 | 2,697,657,908.35 | 2,074,811,249.42 | 1,404,443,712.82 |
| 营业收入 | 618,542,128.87 | 2,697,657,908.35 | 2,074,811,249.42 | 1,404,443,712.82 |
| 二、营业总成本 | 510,997,863.52 | 2,243,948,641.01 | 1,699,560,309.6 | 1,136,581,136.32 |
| 营业成本 | 188,523,965.56 | 812,626,479.75 | 613,788,582.06 | 414,111,468.83 |
| 税金及附加 | 2,143,394.55 | 17,546,424.75 | 11,992,211.91 | 7,564,626.86 |
| 销售费用 | 193,890,188.65 | 780,848,897.96 | 594,490,949.81 | 405,272,373.34 |
| 管理费用 | 88,230,167.79 | 442,700,593.26 | 325,236,112.34 | 208,553,418.56 |
| 研发费用 | 48,418,019.42 | 238,929,301.47 | 188,136,393.76 | 125,400,292.66 |
| 财务费用 | -10,207,872.45 | -48,703,056.18 | -34,083,940.28 | -24,321,043.93 |
| 其中:利息费用 | 2,520,367.46 | 18,061,010.12 | 8,977,793.9 | 7,523,197.25 |
| 其中:利息收入 | 13,672,758.05 | 73,961,580 | 54,883,656.75 | 36,759,125.58 |
| 加:公允价值变动收益 | 117,883.95 | 25,915,335.3 | -345,330.26 | -716,701.54 |
| 加:投资收益 | -81,191.87 | 1,002,272.17 | 96,833.95 | 320,874.07 |
| 资产处置收益 | 359,499.7 | -16,481.37 | 217,985.29 | 405,699.2 |
| 资产减值损失(新) | -6,593,823.48 | -32,238,397.56 | -13,132,183.94 | -12,517,294.95 |
| 信用减值损失(新) | 22,975.45 | 2,229,268.12 | 306,860.88 | 473,342.54 |
| 其他收益 | 2,437,251.71 | 44,160,167.51 | 25,135,964.94 | 6,962,620.24 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 103,806,860.81 | 494,761,431.51 | 387,531,070.68 | 262,791,116.06 |
| 加:营业外收入 | 49,064.39 | 988,310.02 | 252,513.63 | 36,492.26 |
| 减:营业外支出 | 528,616.56 | 29,604,284.75 | 1,343,144.88 | 335,415.51 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 103,327,308.64 | 466,145,456.78 | 386,440,439.43 | 262,492,192.81 |
| 减:所得税费用 | 19,516,420.06 | 89,902,154.56 | 70,457,746.73 | 44,833,912.29 |
| 六、净利润 | 83,810,888.58 | 376,243,302.22 | 315,982,692.7 | 217,658,280.52 |
| 持续经营净利润 | 83,810,888.58 | 376,243,302.22 | 315,982,692.7 | 217,658,280.52 |
| 归属于母公司股东的净利润 | 90,312,072.67 | 420,446,906.16 | 340,889,084.77 | 235,283,704.91 |
| 少数股东损益 | -6,501,184.09 | -44,203,603.94 | -24,906,392.07 | -17,625,424.39 |
| (一)基本每股收益 | 0.39 | 1.8 | 1.46 | 1.01 |
| (二)稀释每股收益 | 0.39 | 1.8 | 1.46 | 1.01 |
| 八、其他综合收益 | 22,479,538.35 | -110,792,943.52 | 2,257,044.78 | -20,920,853.33 |
| 归属于母公司股东的其他综合收益 | 19,212,366.52 | -111,550,239.01 | -1,271,933.14 | -20,938,432.41 |
| 九、综合收益总额 | 106,290,426.93 | 265,450,358.7 | 318,239,737.48 | 196,737,427.19 |
| 归属于母公司股东的综合收益总额 | 109,524,439.19 | 308,896,667.15 | 339,617,151.63 | 214,345,272.5 |
| 归属于少数股东的综合收益总额 | -3,234,012.26 | -43,446,308.45 | -21,377,414.15 | -17,607,845.31 |
| 公告日期 | 2025-04-26 | 2025-03-22 | 2024-10-26 | 2024-08-17 |
| 审计意见(境内) | | 标准无保留意见 | | |